<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38675914</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Herpesvirus Infection of Endothelial Cells as a Systemic Pathological Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">572</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16040572</ELocationID><Abstract><AbstractText>Understanding the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is critical for advancing treatment options. This review explores the novel hypothesis that a herpesvirus infection of endothelial cells (ECs) may underlie ME/CFS symptomatology. We review evidence linking herpesviruses to persistent EC infection and the implications for endothelial dysfunction, encompassing blood flow regulation, coagulation, and cognitive impairment-symptoms consistent with ME/CFS and Long COVID. This paper provides a synthesis of current research on herpesvirus latency and reactivation, detailing the impact on ECs and subsequent systemic complications, including latent modulation and long-term maladaptation. We suggest that the chronicity of ME/CFS symptoms and the multisystemic nature of the disease may be partly attributable to herpesvirus-induced endothelial maladaptation. Our conclusions underscore the necessity for further investigation into the prevalence and load of herpesvirus infection within the ECs of ME/CFS patients. This review offers conceptual advances by proposing an endothelial infection model as a systemic mechanism contributing to ME/CFS, steering future research toward potentially unexplored avenues in understanding and treating this complex syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Jean M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-2584-021X</Identifier><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Private Bag X1, Matieland 7602, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0001-5838-7963</Identifier><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Private Bag X1, Matieland 7602, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Building 220, Chemitorvet 200, 2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9108-2384</Identifier><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Private Bag X1, Matieland 7602, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>142142</GrantID><Agency>National Research Foundation</Agency><Country/></Grant><Grant><GrantID>NNF10CC1016517</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="Y">Endothelial Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006564" MajorTopicYN="N">Herpesviridae</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006566" MajorTopicYN="Y">Herpesviridae Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017735" MajorTopicYN="N">Virus Latency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">endothelial cells</Keyword><Keyword MajorTopicYN="N">herpesvirus</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38675914</ArticleId><ArticleId IdType="pmc">PMC11053605</ArticleId><ArticleId IdType="doi">10.3390/v16040572</ArticleId><ArticleId IdType="pii">v16040572</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lim E.-J., Son C.-G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2020;18:289. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa-Dzelzkaleja S., Krumina A., Capenko S., Nora-Krukle Z., Gravelsina S., Vilmane A., Ievina L., Shoenfeld Y., Murovska M. The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome. J. Transl. Med. 2023;21:33. doi: 10.1186/s12967-023-03887-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03887-0</ArticleId><ArticleId IdType="pmc">PMC9847171</ArticleId><ArticleId IdType="pubmed">36653846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza M.E. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back! Biomolecules. 2021;11:185. doi: 10.3390/biom11020185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11020185</ArticleId><ArticleId IdType="pmc">PMC7912523</ArticleId><ArticleId IdType="pubmed">33572802</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasimir F., Toomey D., Liu Z., Kaiping A.C., Ariza M.E., Prusty B.K. Tissue specific signature of HHV-6 infection in ME/CFS. Front. Mol. Biosci. 2022;9:1044964. doi: 10.3389/fmolb.2022.1044964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.1044964</ArticleId><ArticleId IdType="pmc">PMC9795011</ArticleId><ArticleId IdType="pubmed">36589231</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E., Reshkova V., Kumanova A., Raleva S., Alexandrova D., Capo N., Murovska M. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 2020;92:3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B.S., Alharshawi K., Mena-Palomo I., Lafuse W.P., Ariza M.E. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities. JCI Insight. 2022;7:e158193. doi: 10.1172/jci.insight.158193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.158193</ArticleId><ArticleId IdType="pmc">PMC9220958</ArticleId><ArticleId IdType="pubmed">35482424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M., Paiva B., Montero-Mateo R., Garcia N., Zabaleta A. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. Front. Immunol. 2021;12:656797. doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D.M., Cox B., Lafuse W.P., Ariza M.E. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Clin. Ther. 2019;41:848&#x2013;863. doi: 10.1016/j.clinthera.2019.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.04.009</ArticleId><ArticleId IdType="pmc">PMC6525645</ArticleId><ArticleId IdType="pubmed">31040055</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozhgani S.-H., Rajabi F., Qurbani M., Erfani Y., Yaslianifard S., Moosavi A., Pourrostami K., Bagheri A.B., Soleimani A., Behzadian F., et al. Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis. Intervirology. 2021;65:49&#x2013;57. doi: 10.1159/000517930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000517930</ArticleId><ArticleId IdType="pmc">PMC8820437</ArticleId><ArticleId IdType="pubmed">34348314</ArticleId></ArticleIdList></Reference><Reference><Citation>Navaneetharaja N., Griffiths V., Wileman T., Carding S.R. A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)? J. Clin. Med. 2016;5:55. doi: 10.3390/jcm5060055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm5060055</ArticleId><ArticleId IdType="pmc">PMC4929410</ArticleId><ArticleId IdType="pubmed">27275835</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksen W. ME/CFS, case definition, and serological response to Epstein-Barr virus. A systematic literature review. Fatigue Biomed. Health Behav. 2018;6:220&#x2013;234. doi: 10.1080/21641846.2018.1503125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2018.1503125</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton O.L., Harris-Arnold A., Schaffert S., Krams S.M., Martinez O.M. The interplay between Epstein-Barr virus and B lymphocytes: Implications for infection, immunity, and disease. Immunol. Res. 2014;58:268&#x2013;276. doi: 10.1007/s12026-014-8496-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-014-8496-1</ArticleId><ArticleId IdType="pmc">PMC4199828</ArticleId><ArticleId IdType="pubmed">24619311</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinzger C., Grefte A., Plachter B., Gouw A.S., The T.H., Jahn G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 1995;76:741&#x2013;750. doi: 10.1099/0022-1317-76-4-741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-76-4-741</ArticleId><ArticleId IdType="pubmed">9049319</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler B., Sinzger C. Endothelial cells in human cytomegalovirus infection: One host cell out of many or a crucial target for virus spread? Thromb. Haemost. 2009;102:1057&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pubmed">19967135</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherbakov N., Szklarski M., Hartwig J., Sotzny F., Lorenz S., Meyer A., Grabowski P., Doehner W., Scheibenbogen C. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. ESC Heart Fail. 2020;7:1064&#x2013;1071. doi: 10.1002/ehf2.12633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12633</ArticleId><ArticleId IdType="pmc">PMC7261521</ArticleId><ArticleId IdType="pubmed">32154656</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rland K., Sandvik M.K., Rekeland I.G., Ribu L., Sm&#xe5;stuen M.C., Mella O., Fluge &#xd8;. Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&#x2013;Results from Open-Label Cyclophosphamide Intervention Study. Front. Med. 2021;8:642710. doi: 10.3389/fmed.2021.642710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.642710</ArticleId><ArticleId IdType="pmc">PMC8019750</ArticleId><ArticleId IdType="pubmed">33829023</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandvik M.K., S&#xf8;rland K., Leirgul E., Rekeland I.G., Stavland C.S., Mella O., Fluge &#xd8;. Endothelial dysfunction in ME/CFS patients. PLoS ONE. 2023;18:e0280942. doi: 10.1371/journal.pone.0280942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0280942</ArticleId><ArticleId IdType="pmc">PMC9894436</ArticleId><ArticleId IdType="pubmed">36730360</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauensteiner J., Bertinat R., Le&#xf3;n L.E., Riederer M., Sep&#xfa;lveda N., Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients. Sci. Rep. 2021;11:10604. doi: 10.1038/s41598-021-89834-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89834-9</ArticleId><ArticleId IdType="pmc">PMC8134566</ArticleId><ArticleId IdType="pubmed">34011981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertinat R., Villalobos-Labra R., Hofmann L., Blauensteiner J., Sep&#xfa;lveda N., Westermeier F. Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients. Vasc. Pharmacol. 2022;143:106953. doi: 10.1016/j.vph.2022.106953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106953</ArticleId><ArticleId IdType="pubmed">35074481</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton D.J., Kennedy G., Chan K.K., Lang C.C., Belch J.J., Khan F. Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int. J. Cardiol. 2012;154:335&#x2013;336. doi: 10.1016/j.ijcard.2011.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.10.030</ArticleId><ArticleId IdType="pubmed">22078396</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaskamp L., Roubal C., Uddin S., Sotzny F., Kedor C., Bauer S., Scheibenbogen C., Seifert M. Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro. Cells. 2022;11:2376. doi: 10.3390/cells11152376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152376</ArticleId><ArticleId IdType="pmc">PMC9367589</ArticleId><ArticleId IdType="pubmed">35954219</ArticleId></ArticleIdList></Reference><Reference><Citation>Cambras T., Zer&#xf3;n-Rugerio M.F., D&#xed;ez-Noguera A., Zaragoz&#xe1; M.C., Domingo J.C., Sanmartin-Senta&#xf1;es R., Alegre-Martin J., Castro-Marrero J. Skin Temperature Circadian Rhythms and Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Role of Endothelin-1 in the Vascular Tone Dysregulation. Int. J. Mol. Sci. 2023;24:4835. doi: 10.3390/ijms24054835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054835</ArticleId><ArticleId IdType="pmc">PMC10003028</ArticleId><ArticleId IdType="pubmed">36902264</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen C.M.C.v., Rowe P.C., Visser F.C. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medicina. 2022;58:28. doi: 10.3390/medicina58010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C.M.C., Rowe P.C., Visser F.C. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin. Neurophysiol. Pract. 2021;6:245&#x2013;255. doi: 10.1016/j.cnp.2021.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2021.09.001</ArticleId><ArticleId IdType="pmc">PMC8505270</ArticleId><ArticleId IdType="pubmed">34667909</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C.M.C., Rowe P.C., Visser F.C. Cerebral Blood Flow Is Reduced in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients During Mild Orthostatic Stress Testing: An Exploratory Study at 20 Degrees of Head-Up Tilt Testing. Healthcare. 2020;8:169. doi: 10.3390/healthcare8020169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8020169</ArticleId><ArticleId IdType="pmc">PMC7349207</ArticleId><ArticleId IdType="pubmed">32545797</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C.M.C., Verheugt F.W.A., Rowe P.C., Visser F.C. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin. Neurophysiol. Pract. 2020;5:50&#x2013;58. doi: 10.1016/j.cnp.2020.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7044650</ArticleId><ArticleId IdType="pubmed">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>Staud R., Boissoneault J., Craggs J.G., Lai S., Robinson M.E. Task related cerebral blood flow changes of patients with chronic fatigue syndrome: An arterial spin labeling study. Fatigue Biomed. Health Behav. 2018;6:63&#x2013;79. doi: 10.1080/21641846.2018.1453919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2018.1453919</ArticleId><ArticleId IdType="pmc">PMC5914525</ArticleId><ArticleId IdType="pubmed">29707427</ArticleId></ArticleIdList></Reference><Reference><Citation>Boissoneault J., Letzen J., Robinson M., Staud R. Cerebral blood flow and heart rate variability predict fatigue severity in patients with chronic fatigue syndrome. Brain Imaging Behav. 2019;13:789&#x2013;797. doi: 10.1007/s11682-018-9897-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-9897-x</ArticleId><ArticleId IdType="pmc">PMC6274602</ArticleId><ArticleId IdType="pubmed">29855991</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswal B., Kunwar P., Natelson B.H. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J. Neurol. Sci. 2011;301:9&#x2013;11. doi: 10.1016/j.jns.2010.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.11.018</ArticleId><ArticleId IdType="pmc">PMC3139492</ArticleId><ArticleId IdType="pubmed">21167506</ArticleId></ArticleIdList></Reference><Reference><Citation>COSTA D.C., Tannock C., Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM Int. J. Med. 1995;88:767&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">8542261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiuchi K., Farkas J., Natelson B.H. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin. Physiol. Funct. Imaging. 2006;26:83&#x2013;86. doi: 10.1111/j.1475-097X.2006.00649.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-097X.2006.00649.x</ArticleId><ArticleId IdType="pubmed">16494597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shungu D.C., Weiduschat N., Murrough J.W., Mao X., Pillemer S., Dyke J.P., Medow M.S., Natelson B.H., Stewart J.M., Mathew S.J. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 2012;25:1073&#x2013;1087. doi: 10.1002/nbm.2772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2772</ArticleId><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Julin P., Li T.-Q. Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Tomography. 2021;7:675&#x2013;687. doi: 10.3390/tomography7040056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tomography7040056</ArticleId><ArticleId IdType="pmc">PMC8628916</ArticleId><ArticleId IdType="pubmed">34842817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Calcaterra I., Molino A., Moretta P., Lupoli R., Spedicato G.A., Papa A., Motta A., Maniscalco M., Di Minno M.N.D. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines. 2021;9:957. doi: 10.3390/biomedicines9080957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080957</ArticleId><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K., Gronski P.A., Kiyan Y., Seeliger B., Bertram A., Pape T., Welte T., Hoeper M.M., Haller H., David S. Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19. Am. J. Respir. Crit. Care Med. 2020;202:1178&#x2013;1181. doi: 10.1164/rccm.202007-2676LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2676LE</ArticleId><ArticleId IdType="pmc">PMC7560808</ArticleId><ArticleId IdType="pubmed">32833500</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., Volk H.D., et al. Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany&#x2014;A first analysis of a prospective observational study. medRxiv. 2021. medRxiv:06.21249256.</Citation></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. Dis. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W., Walker M., Sweetman E., Helliwell A., Peppercorn K., Edgar C., Blair A., Chatterjee A. Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses. Front. Neurol. 2022;13:877772. doi: 10.3389/fneur.2022.877772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.877772</ArticleId><ArticleId IdType="pmc">PMC9174654</ArticleId><ArticleId IdType="pubmed">35693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kruger A., Proal A., Kell D.B., Pretorius E. The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Pharmaceuticals. 2022;15:931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The potential role of ischaemia&#x2013;reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: Evidence, mechanisms, and therapeutic implications. Biochem. J. 2022;479:1653&#x2013;1708. doi: 10.1042/BCJ20220154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubshder G., Khan M., Venter C., Pretorius J., Kell D., Pretorius E. Treatment of Long COVID symptoms with triple anticoagulant therapy. Res. Sq. 2023. Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2697680/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Hampton D., Marques de Menezes E.G., Deng X., Montoya J.G., Anderson J., Norris P.J. Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Immunol. 2022;13:841910. doi: 10.3389/fimmu.2022.841910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.841910</ArticleId><ArticleId IdType="pmc">PMC8931328</ArticleId><ArticleId IdType="pubmed">35309313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahanbani F., Maynard R.D., Sing J.C., Jahanbani S., Perrino J.J., Spacek D.V., Davis R.W., Snyder M.P. Phenotypic characteristics of peripheral immune cells of Myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: A pilot study. PLoS ONE. 2022;17:e0272703. doi: 10.1371/journal.pone.0272703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272703</ArticleId><ArticleId IdType="pmc">PMC9362953</ArticleId><ArticleId IdType="pubmed">35943990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed F., Vu L.T., Zhu H., Iu D.S.H., Fogarty E.A., Kwak Y., Chen W., Franconi C.J., Munn P.R., Tate A.E., et al. Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation. bioRxiv. 2022 bioRxiv:13.512091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10829790</ArticleId><ArticleId IdType="pubmed">38232699</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg D., Berg L.H., Couvaras J., Harrison H. Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: An explanatory model and approach to laboratory diagnosis. Blood Coagul. Fibrinolysis. 1999;10:435&#x2013;438. doi: 10.1097/00001721-199910000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-199910000-00006</ArticleId><ArticleId IdType="pubmed">10695770</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hinsbergh V.W.M. Endothelium&#x2014;Role in regulation of coagulation and inflammation. Semin. Immunopathol. 2012;34:93&#x2013;106. doi: 10.1007/s00281-011-0285-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-011-0285-5</ArticleId><ArticleId IdType="pmc">PMC3233666</ArticleId><ArticleId IdType="pubmed">21845431</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer K., Zieger B. Endothelial cells and coagulation. Cell Tissue Res. 2022;387:391&#x2013;398. doi: 10.1007/s00441-021-03471-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-021-03471-2</ArticleId><ArticleId IdType="pmc">PMC8975780</ArticleId><ArticleId IdType="pubmed">34014399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against &#xdf;2-adrenergic receptors. Autoimmun. Rev. 2020;19:102527. doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType="pubmed">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C., Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Transl. Med. 2021;19:471. doi: 10.1186/s12967-021-03143-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType="pmc">PMC8607226</ArticleId><ArticleId IdType="pubmed">34809664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A., Osorio C., Zapata Mart&#xed;n del Campo C., Pereida S., Maurer S., Maldonado J.C., Kozlakidis Z. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. Front. Cell. Neurosci. 2021;15:673217. doi: 10.3389/fncel.2021.673217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.673217</ArticleId><ArticleId IdType="pmc">PMC8267916</ArticleId><ArticleId IdType="pubmed">34248502</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko S., Krumina A., Logina I., Rasa S., Chistjakovs M., Sultanova A., Viksna L., Murovska M. Association of Active Human Herpesvirus-6, -7 and Parvovirus B19 Infection with Clinical Outcomes in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Adv. Virol. 2012;2012:205085. doi: 10.1155/2012/205085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/205085</ArticleId><ArticleId IdType="pmc">PMC3426163</ArticleId><ArticleId IdType="pubmed">22927850</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J., Rizwan M., B&#xf6;hlin-Wiener A., Elfaitouri A., Julin P., Zachrisson O., Ros&#xe9;n A., Gottfries C.-G. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Front. Immunol. 2019;10:1946. doi: 10.3389/fimmu.2019.01946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01946</ArticleId><ArticleId IdType="pmc">PMC6702656</ArticleId><ArticleId IdType="pubmed">31475007</ArticleId></ArticleIdList></Reference><Reference><Citation>Ban S., Goto Y., Kamada K., Takahama M., Watanabe H., Iwahori T., Takeuchi H. Systemic granulomatous arteritis associated with Epstein-Barr virus infection. Virchows Arch. 1999;434:249&#x2013;254. doi: 10.1007/s004280050336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004280050336</ArticleId><ArticleId IdType="pubmed">10190306</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarner J., Unger E.R. Association of Epstein-Barr virus in epithelioid angiomatosis of AIDS patients. Am. J. Surg. Pathol. 1990;14:956&#x2013;960. doi: 10.1097/00000478-199010000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000478-199010000-00009</ArticleId><ArticleId IdType="pubmed">2169709</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina A., Cirone M., York M., Lenna S., Padilla C., Mclaughlin S., Faggioni A., Lafyatis R., Trojanowska M., Farina G.A. Epstein&#x2013;Barr Virus Infection Induces Aberrant TLR Activation Pathway and Fibroblast&#x2013;Myofibroblast Conversion in Scleroderma. J. Investig. Dermatol. 2014;134:954&#x2013;964. doi: 10.1038/jid.2013.423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2013.423</ArticleId><ArticleId IdType="pmc">PMC3961515</ArticleId><ArticleId IdType="pubmed">24129067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K., Kuwabara S., Mori M., Arai K., Yamamoto T., Hattori T. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein&#x2013;Barr virus infection. Muscle Nerve. 2003;27:113&#x2013;116. doi: 10.1002/mus.10287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10287</ArticleId><ArticleId IdType="pubmed">12508305</ArticleId></ArticleIdList></Reference><Reference><Citation>Truszewska A., Wirkowska A., Gala K., Truszewski P., Krzemie&#x144;-Ojak L., Mucha K., P&#x105;czek L., Foroncewicz B. EBV load is associated with cfDNA fragmentation and renal damage in SLE patients. Lupus. 2021;30:1214&#x2013;1225. doi: 10.1177/09612033211010339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211010339</ArticleId><ArticleId IdType="pubmed">33866897</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones K., Rivera C., Sgadari C., Franklin J., E Max E., Bhatia K., Tosato G. Infection of human endothelial cells with Epstein-Barr virus. J. Exp. Med. 1995;182:1213&#x2013;1221. doi: 10.1084/jem.182.5.1213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.182.5.1213</ArticleId><ArticleId IdType="pmc">PMC2192185</ArticleId><ArticleId IdType="pubmed">7595192</ArticleId></ArticleIdList></Reference><Reference><Citation>Casiraghi C., Dorovini-Zis K., Horwitz M.S. Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis. J. Neuroimmunol. 2011;230:173&#x2013;177. doi: 10.1016/j.jneuroim.2010.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.08.003</ArticleId><ArticleId IdType="pubmed">20826008</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina A., Rosato E., York M., Gewurz B.E., Trojanowska M., Farina G.A. Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma. Front. Immunol. 2021;12:651013. doi: 10.3389/fimmu.2021.651013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.651013</ArticleId><ArticleId IdType="pmc">PMC8089375</ArticleId><ArticleId IdType="pubmed">33953718</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso A., Rotola A., Comar M., Favilli F., Galvan M., Tosetti M., Campello C., Caselli E., Alessandri G., Grassi M., et al. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J. Med. Virol. 2002;67:528&#x2013;533. doi: 10.1002/jmv.10133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10133</ArticleId><ArticleId IdType="pubmed">12115999</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo R., D&#x2019;accolti M., Bortolotti D., Caccuri F., Caruso A., Di Luca D., Caselli E. Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G. Sci. Rep. 2018;8:17683. doi: 10.1038/s41598-018-36146-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36146-0</ArticleId><ArticleId IdType="pmc">PMC6283866</ArticleId><ArticleId IdType="pubmed">30523283</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso A., Favilli F., Rotola A., Comar M., Horejsh D., Alessandri G., Grassi M., Di Luca D., Fiorentini S. Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J. Med. Virol. 2003;70:451&#x2013;458. doi: 10.1002/jmv.10416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10416</ArticleId><ArticleId IdType="pubmed">12767010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotola A., Di Luca D., Cassai E., Ricotta D., Giulio A., Turano A., Caruso A., Muneretto C. Human herpesvirus 6 infects and replicates in aortic endothelium. J. Clin. Microbiol. 2000;38:3135&#x2013;3136. doi: 10.1128/JCM.38.8.3135-3136.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.38.8.3135-3136.2000</ArticleId><ArticleId IdType="pmc">PMC87214</ArticleId><ArticleId IdType="pubmed">11001665</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.A., Shanley J.D. Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J. Gen. Virol. 1998;79:1247&#x2013;1256. doi: 10.1099/0022-1317-79-5-1247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-79-5-1247</ArticleId><ArticleId IdType="pubmed">9603340</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy S., Eliassen E., Krueger G. Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children. Ann. Pediatr. Cardiol. 2017;10:259&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5594937</ArticleId><ArticleId IdType="pubmed">28928612</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser M.R., Tracy P.B., Vercellotti G.M., Goodman J.L., White J.G., Jacob H.S. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc. Natl. Acad. Sci. USA. 1988;85:8227&#x2013;8230. doi: 10.1073/pnas.85.21.8227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.21.8227</ArticleId><ArticleId IdType="pmc">PMC282402</ArticleId><ArticleId IdType="pubmed">2847155</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonsato V., Buttiglieri S., Deregibus M.C., Bussolati B., Caselli E., Di Luca D., Camussi G. PAX2 expression by HHV-8&#x2013;infected endothelial cells induced a proangiogenic and proinvasive phenotype. Blood. 2008;111:2806&#x2013;2815. doi: 10.1182/blood-2007-04-085555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-04-085555</ArticleId><ArticleId IdType="pubmed">18056486</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolcino M., Puccetti A., Barbieri A., Bason C., Tinazzi E., Ottria A., Patuzzo G., Martinelli N., Lunardi C. Infections and autoimmunity: Role of human cytomegalovirus in autoimmune endothelial cell damage. Lupus. 2015;24:419&#x2013;432. doi: 10.1177/0961203314558677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314558677</ArticleId><ArticleId IdType="pubmed">25801885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunardi C., Bason C., Corrocher R., Puccetti A. Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol. 2005;26:19&#x2013;24. doi: 10.1016/j.it.2004.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.10.009</ArticleId><ArticleId IdType="pubmed">15629405</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen K., Xu L., Chen D., Tang W., Huang Y. Human cytomegalovirus-encoded miR-UL112 contributes to HCMV-mediated vascular diseases by inducing vascular endothelial cell dysfunction. Virus Genes. 2018;54:172&#x2013;181. doi: 10.1007/s11262-018-1532-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-018-1532-9</ArticleId><ArticleId IdType="pubmed">29330663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaiw K.-C., Mohammad A.-A., Costa H., Taher C., Badrnya S., Assinger A., Wilhelmi V., Ananthaseshan S., Estekizadeh A., Davoudi B., et al. Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies? Open Forum Infect. Dis. 2015;2:ofv155. doi: 10.1093/ofid/ofv155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofv155</ArticleId><ArticleId IdType="pmc">PMC4690546</ArticleId><ArticleId IdType="pubmed">26719843</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.I. Herpesvirus Latency. J. Clin. Investig. 2020;130:3361&#x2013;3369. doi: 10.1172/JCI136225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI136225</ArticleId><ArticleId IdType="pmc">PMC7324166</ArticleId><ArticleId IdType="pubmed">32364538</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidner-Glunde M., Kruminis-Kaszkiel E., Savanagouder M. Herpesviral Latency&#x2014;Common Themes. Pathogens. 2020;9:125. doi: 10.3390/pathogens9020125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9020125</ArticleId><ArticleId IdType="pmc">PMC7167855</ArticleId><ArticleId IdType="pubmed">32075270</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso A., Caselli E., Fiorentini S., Rotola A., Prandini A., Garrafa E., Saba E., Alessandri G., Cassai E., Di Luca D. U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis. Proc. Natl. Acad. Sci. USA. 2009;106:20446&#x2013;20451. doi: 10.1073/pnas.0905535106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905535106</ArticleId><ArticleId IdType="pmc">PMC2787175</ArticleId><ArticleId IdType="pubmed">19918067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann D., Luka J., Kallakury B., Rusnock E., Azumi N. Laboratory Investigation. Nature Publishing Group; New York, NY, USA: 2023. Immortalization and transformation of human endothelial cells infected with human herpesvirus-6 Objective Background.</Citation></Reference><Reference><Citation>Brewer J.H., Berg D. Hypercoaguable State Associated with Active Human Herpesvirus-6 (HHV-6) Viremia in Patients with Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 2001;8:111&#x2013;116. doi: 10.1300/J092v08n03_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v08n03_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Hollmann C., Kalanidhi S., Grothey A., Keating S., Mena-Palomo I., Lamer S., Schlosser A., Kaiping K., Scheller C., et al. Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and long COVID. medRxiv. 2023. medRxiv:2023.06.23.23291827.</Citation></Reference><Reference><Citation>Kaprelyants A.S., Gottschal J.C., Kell D.B. Dormancy in non-sporulating bacteria. FEMS Microbiol. Rev. 1993;10:271&#x2013;285. doi: 10.1111/j.1574-6968.1993.tb05871.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.1993.tb05871.x</ArticleId><ArticleId IdType="pubmed">8318260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Kaprelyants A.S., Weichart D.H., Harwood C.R., Barer M.R. Viability and activity in readily culturable bacteria: A review and discussion of the practical issues. Antonie van Leeuwenhoek. 1998;73:169&#x2013;187. doi: 10.1023/A:1000664013047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1000664013047</ArticleId><ArticleId IdType="pubmed">9717575</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J., Goodrum F., Knox K., Smithey M.J. Known unknowns: How might the persistent herpesvirome shape immunity and aging? Curr. Opin. Immunol. 2017;48:23&#x2013;30. doi: 10.1016/j.coi.2017.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2017.07.011</ArticleId><ArticleId IdType="pmc">PMC5682194</ArticleId><ArticleId IdType="pubmed">28780492</ArticleId></ArticleIdList></Reference><Reference><Citation>Simanek A.M., Dowd J.B., Pawelec G., Melzer D., Dutta A., Aiello A.E. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE. 2011;6:e16103. doi: 10.1371/journal.pone.0016103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0016103</ArticleId><ArticleId IdType="pmc">PMC3040745</ArticleId><ArticleId IdType="pubmed">21379581</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin B.D., Verweij M.C., Wiertz E.J.H.J. Herpesviruses and immunity: The art of evasion. Vet. Microbiol. 2010;143:89&#x2013;100. doi: 10.1016/j.vetmic.2010.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2010.02.017</ArticleId><ArticleId IdType="pubmed">20303681</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann O., Zdunek S., Felker A., Salehpour M., Alkass K., Bernard S., Sjostrom S.L., Szewczykowska M., Jackowska T., dos Remedios C., et al. Dynamics of Cell Generation and Turnover in the Human Heart. Cell. 2015;161:1566&#x2013;1575. doi: 10.1016/j.cell.2015.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.05.026</ArticleId><ArticleId IdType="pubmed">26073943</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson B., Denekamp J. Endothelial proliferation in tumours and normal tissues: Continuous labelling studies. Br. J. Cancer. 1984;49:405&#x2013;413. doi: 10.1038/bjc.1984.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.1984.66</ArticleId><ArticleId IdType="pmc">PMC1976759</ArticleId><ArticleId IdType="pubmed">6201181</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong A., Clarke-Katzenberg R.H., Valenzuela G., Izumi K.M., Millan M.T. Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis. Transplantation. 2004;78:41&#x2013;49. doi: 10.1097/01.TP.0000129805.02631.EF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TP.0000129805.02631.EF</ArticleId><ArticleId IdType="pubmed">15257037</ArticleId></ArticleIdList></Reference><Reference><Citation>Takemoto M., Mori Y., Ueda K., Kondo K., Yamanishi K. Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J. Gen. Virol. 2004;85:869&#x2013;879. doi: 10.1099/vir.0.19626-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19626-0</ArticleId><ArticleId IdType="pubmed">15039530</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawelec G., Akbar A., Beverley P., Caruso C., Derhovanessian E., F&#xfc;l&#xf6;p T., Griffiths P., Grubeck-Loebenstein B., Hamprecht K., Jahn G., et al. Immunosenescence and Cytomegalovirus: Where do we stand after a decade? Immun. Ageing. 2010;7:13. doi: 10.1186/1742-4933-7-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-7-13</ArticleId><ArticleId IdType="pmc">PMC2939591</ArticleId><ArticleId IdType="pubmed">20822513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogestyn J.M., Mock D.J., Mayer-Proschel M. Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology. Neural Regen. Res. 2018;13:211&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5879884</ArticleId><ArticleId IdType="pubmed">29557362</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H., Qu J., Peng Q., Gan R. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med. Microbiol. Immunol. 2019;208:573&#x2013;583. doi: 10.1007/s00430-018-0570-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-018-0570-1</ArticleId><ArticleId IdType="pmc">PMC6746687</ArticleId><ArticleId IdType="pubmed">30386928</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgui de Oliveira D., M&#xfc;ller-Coan B.G., Pagano J.S. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers. Trends Microbiol. 2016;24:649&#x2013;664. doi: 10.1016/j.tim.2016.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2016.03.008</ArticleId><ArticleId IdType="pmc">PMC5489061</ArticleId><ArticleId IdType="pubmed">27068530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda T., Yajima M., Ikuta K. Epstein-Barr virus strain variation and cancer. Cancer Sci. 2019;110:1132&#x2013;1139. doi: 10.1111/cas.13954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.13954</ArticleId><ArticleId IdType="pmc">PMC6447851</ArticleId><ArticleId IdType="pubmed">30697862</ArticleId></ArticleIdList></Reference><Reference><Citation>Niller H.H., Wolf H., Ay E., Minarovits J. Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease. Adv. Exp. Med. Biol. 2011;711:82&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">21627044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-A., Diamond Margaret E., Yates John L. Genetic Evidence that EBNA-1 Is Needed for Efficient, Stable Latent Infection by Epstein-Barr Virus. J. Virol. 1999;73:2974&#x2013;2982. doi: 10.1128/JVI.73.4.2974-2982.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.4.2974-2982.1999</ArticleId><ArticleId IdType="pmc">PMC104057</ArticleId><ArticleId IdType="pubmed">10074147</ArticleId></ArticleIdList></Reference><Reference><Citation>Leight E.R., Sugden B. EBNA-1: A protein pivotal to latent infection by Epstein&#x2013;Barr virus. Rev. Med. Virol. 2000;10:83&#x2013;100. doi: 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T</ArticleId><ArticleId IdType="pubmed">10713596</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymula A., Palermo R.D., Bayoumy A., Groves I.J., Ba Abdullah M., Holder B., White R.E. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming na&#xef;ve B cells, and facilitates recruitment of transcription factors to the viral genome. PLoS Pathog. 2018;14:e1006890. doi: 10.1371/journal.ppat.1006890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006890</ArticleId><ArticleId IdType="pmc">PMC5834210</ArticleId><ArticleId IdType="pubmed">29462212</ArticleId></ArticleIdList></Reference><Reference><Citation>Young L.S., Murray P.G. Epstein&#x2013;Barr virus and oncogenesis: From latent genes to tumours. Oncogene. 2003;22:5108&#x2013;5121. doi: 10.1038/sj.onc.1206556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1206556</ArticleId><ArticleId IdType="pubmed">12910248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M.-S., Kieff E. Epstein&#x2013;Barr virus latent genes. Exp. Mol. Med. 2015;47:e131. doi: 10.1038/emm.2014.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.84</ArticleId><ArticleId IdType="pmc">PMC4314583</ArticleId><ArticleId IdType="pubmed">25613728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruhne B., Sompallae R., Marescotti D., Kamranvar S.A., Gastaldello S., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl. Acad. Sci. USA. 2009;106:2313&#x2013;2318. doi: 10.1073/pnas.0810619106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810619106</ArticleId><ArticleId IdType="pmc">PMC2650153</ArticleId><ArticleId IdType="pubmed">19139406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamranvar S.A., Masucci M.G. The Epstein&#x2013;Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia. 2011;25:1017&#x2013;1025. doi: 10.1038/leu.2011.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/leu.2011.35</ArticleId><ArticleId IdType="pmc">PMC3115054</ArticleId><ArticleId IdType="pubmed">21394098</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruhne B., Sompallae R., Masucci M.G. Three Epstein&#x2013;Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene. 2009;28:3997&#x2013;4008. doi: 10.1038/onc.2009.258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2009.258</ArticleId><ArticleId IdType="pubmed">19718051</ArticleId></ArticleIdList></Reference><Reference><Citation>Frappier L. Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses. 2012;4:1537&#x2013;1547. doi: 10.3390/v4091537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4091537</ArticleId><ArticleId IdType="pmc">PMC3499818</ArticleId><ArticleId IdType="pubmed">23170171</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole B.D., Scofield R.H., Harley J.B., James J.A. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006;39:63&#x2013;70. doi: 10.1080/08916930500484849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500484849</ArticleId><ArticleId IdType="pubmed">16455583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz T.V., Brewer R.C., Ho P.P., Moon J.-S., Jude K.M., Fernandez D., Fernandes R.A., Gomez A.M., Nadj G.-S., Bartley C.M., et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature. 2022;603:321&#x2013;327. doi: 10.1038/s41586-022-04432-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04432-7</ArticleId><ArticleId IdType="pmc">PMC9382663</ArticleId><ArticleId IdType="pubmed">35073561</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bellis A., Bellastella G., Pernice V., Cirillo P., Longo M., Maio A., Scappaticcio L., Maiorino M.I., Bellastella A., Esposito K., et al. Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome. J. Clin. Endocrinol. Metab. 2021;106:e5147&#x2013;e5155. doi: 10.1210/clinem/dgab429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab429</ArticleId><ArticleId IdType="pubmed">34254637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., Blanco J., Capelli E., Castro-Marrero J., Steiner S., Murovska M., Scheibenbogen C. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&#x2014;Evidence for an autoimmune disease. Autoimmun. Rev. 2018;17:601&#x2013;609. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neil J.D., Owen T.J., Wood V.H.J., Date K.L., Valentine R., Chukwuma M.B., Arrand J.R., Dawson C.W., Young L.S. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. Pt 11J. Gen. Virol. 2008;89:2833&#x2013;2842. doi: 10.1099/vir.0.2008/003392-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/003392-0</ArticleId><ArticleId IdType="pubmed">18931081</ArticleId></ArticleIdList></Reference><Reference><Citation>Murono S., Inoue H., Tanabe T., Joab I., Yoshizaki T., Furukawa M., Pagano J.S. Induction of cyclooxygenase-2 by Epstein&#x2013;Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. USA. 2001;98:6905&#x2013;6910. doi: 10.1073/pnas.121016998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.121016998</ArticleId><ArticleId IdType="pmc">PMC34451</ArticleId><ArticleId IdType="pubmed">11381123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung C.-P., Raab-Traub N. Epstein-Barr Virus Latent Membrane Protein 1 Induces Expression of the Epidermal Growth Factor Receptor through Effects on Bcl-3 and STAT3. J. Virol. 2008;82:5486&#x2013;5493. doi: 10.1128/JVI.00125-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00125-08</ArticleId><ArticleId IdType="pmc">PMC2395195</ArticleId><ArticleId IdType="pubmed">18367518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kaiser C., Zeidler R., Scheffer B., Ueffing M., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. Embo J. 1999;18:3064&#x2013;3073. doi: 10.1093/emboj/18.11.3064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.11.3064</ArticleId><ArticleId IdType="pmc">PMC1171388</ArticleId><ArticleId IdType="pubmed">10357818</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliopoulos A.G., Young L.S. LMP1 structure and signal transduction. Semin. Cancer Biol. 2001;11:435&#x2013;444. doi: 10.1006/scbi.2001.0410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/scbi.2001.0410</ArticleId><ArticleId IdType="pubmed">11669605</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P.-H., Chou S.-F., Chen C.-L., Hung H., Lai C.-Y., Yang P.-M., Jeng Y.-M., Liaw S.-F., Kuo H.-H., Hsu H.-C., et al. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma. PLoS ONE. 2013;8:e82254. doi: 10.1371/journal.pone.0082254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082254</ArticleId><ArticleId IdType="pmc">PMC3855342</ArticleId><ArticleId IdType="pubmed">24340011</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Jiang L., Yu X.-H., Hu M., Zhang Y.-K., Liu X., He P., Ouyang X. Endocan: A Key Player of Cardiovascular Disease. Front. Cardiovasc. Med. 2021;8:798699. doi: 10.3389/fcvm.2021.798699.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.798699</ArticleId><ArticleId IdType="pmc">PMC8766991</ArticleId><ArticleId IdType="pubmed">35071362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentz G.L., Whitehurst C.B., Pagano J.S. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J. Virol. 2011;85:10144&#x2013;10153. doi: 10.1128/JVI.05035-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05035-11</ArticleId><ArticleId IdType="pmc">PMC3196420</ArticleId><ArticleId IdType="pubmed">21795333</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L., Hu Z.-Y., Dong X., Tan Z., Li W., Tang M., Chen L., Yang L., Tao Y., Jiang Y., et al. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene. 2014;33:4568&#x2013;4578. doi: 10.1038/onc.2014.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2014.32</ArticleId><ArticleId IdType="pmc">PMC4162460</ArticleId><ArticleId IdType="pubmed">24662831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo A.K., Dawson C.W., Young L.S., Ko C., Hau P., Lo K. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells. J. Pathol. 2015;237:238&#x2013;248. doi: 10.1002/path.4575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4575</ArticleId><ArticleId IdType="pubmed">26096068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Yan B., Lai W., Shi Y., Xiao D., Jia J., Liu S., Li H., Lu J., Li Z., et al. Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8. Oncogene. 2015;34:6079&#x2013;6091. doi: 10.1038/onc.2015.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2015.53</ArticleId><ArticleId IdType="pmc">PMC4564361</ArticleId><ArticleId IdType="pubmed">25745994</ArticleId></ArticleIdList></Reference><Reference><Citation>Hino R., Uozaki H., Murakami N., Ushiku T., Shinozaki A., Ishikawa S., Morikawa T., Nakaya T., Sakatani T., Takada K., et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 2009;69:2766&#x2013;2774. doi: 10.1158/0008-5472.CAN-08-3070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-3070</ArticleId><ArticleId IdType="pubmed">19339266</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K.A., Lupey L.N., Tempera I. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1. J. Virol. 2016;90:8520&#x2013;8530. doi: 10.1128/JVI.01180-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01180-16</ArticleId><ArticleId IdType="pmc">PMC5021435</ArticleId><ArticleId IdType="pubmed">27440880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhang P., Feng J., Li R., Chen J., Zheng W.V., Zhang H., Yao P. LMP1 mediates tumorigenesis through persistent epigenetic modifications and PGC1&#x3b2; upregulation. Oncol. Rep. 2023;49:53. doi: 10.3892/or.2023.8490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2023.8490</ArticleId><ArticleId IdType="pmc">PMC9926514</ArticleId><ArticleId IdType="pubmed">36734290</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.-T., Chen Y.-R., Chen S.-C., Hu C.-Y., Lin C.-S., Chang Y.-T., Wang W.-B., Chen J.-Y. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene. 2004;23:2531&#x2013;2539. doi: 10.1038/sj.onc.1207375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207375</ArticleId><ArticleId IdType="pubmed">14716302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.Y., Sugden B. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene. 2008;27:2833&#x2013;2842. doi: 10.1038/sj.onc.1210946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1210946</ArticleId><ArticleId IdType="pubmed">18037963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.Y., Sugden B. The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood. 2008;111:2280&#x2013;2289. doi: 10.1182/blood-2007-07-100032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-07-100032</ArticleId><ArticleId IdType="pmc">PMC2234060</ArticleId><ArticleId IdType="pubmed">18042799</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L., Shi F., Li Y., Li W., Yu X., Zhao L., Zhou M., Hu J., Luo X., Tang M., et al. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduct. Target. Ther. 2020;5:56. doi: 10.1038/s41392-020-0151-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0151-9</ArticleId><ArticleId IdType="pmc">PMC7237430</ArticleId><ArticleId IdType="pubmed">32433544</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancao C., Hammerschmidt W. Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood. 2007;110:3715&#x2013;3721. doi: 10.1182/blood-2007-05-090142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-05-090142</ArticleId><ArticleId IdType="pmc">PMC2077319</ArticleId><ArticleId IdType="pubmed">17682125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rancan C., Schirrmann L., H&#xfc;ls C., Zeidler R., Moosmann A. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. PLOS Pathog. 2015;11:e1004906. doi: 10.1371/journal.ppat.1004906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004906</ArticleId><ArticleId IdType="pmc">PMC4465838</ArticleId><ArticleId IdType="pubmed">26067064</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwakiri D. Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis. Cancers. 2014;6:1615&#x2013;1630. doi: 10.3390/cancers6031615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers6031615</ArticleId><ArticleId IdType="pmc">PMC4190559</ArticleId><ArticleId IdType="pubmed">25101570</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotola A., Ravaioli T., Gonelli A., Dewhurst S., Cassai E., Di Luca D. U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl. Acad. Sci. USA. 1998;95:13911&#x2013;13916. doi: 10.1073/pnas.95.23.13911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.23.13911</ArticleId><ArticleId IdType="pmc">PMC24961</ArticleId><ArticleId IdType="pubmed">9811900</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell A., Hogestyn J.M., Folts C.J., Lopez B., Pr&#xf6;schel C., Mock D., Mayer-Pr&#xf6;schel M. Expression of the Human Herpesvirus 6A Latency-Associated Transcript U94A Disrupts Human Oligodendrocyte Progenitor Migration. Sci. Rep. 2017;7:3978. doi: 10.1038/s41598-017-04432-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04432-y</ArticleId><ArticleId IdType="pmc">PMC5479784</ArticleId><ArticleId IdType="pubmed">28638124</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccuri F., Sommariva M., Marsico S., Giordano F., Zani A., Giacomini A., Fraefel C., Balsari A., Caruso A. Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94. Cancers. 2019;11:1006. doi: 10.3390/cancers11071006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11071006</ArticleId><ArticleId IdType="pmc">PMC6679437</ArticleId><ArticleId IdType="pubmed">31323788</ArticleId></ArticleIdList></Reference><Reference><Citation>Indari O., Tiwari D., Tanwar M., Kumar R., Jha H.C. Early biomolecular changes in brain microvascular endothelial cells under Epstein&#x2013;Barr virus influence: A Raman microspectroscopic investigation. Integr. Biol. 2022;14:89&#x2013;97. doi: 10.1093/intbio/zyac009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intbio/zyac009</ArticleId><ArticleId IdType="pubmed">35780312</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentz G.L., Jarquin-Pardo M., Chan G., Smith M.S., Sinzger C., Yurochko A.D. Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J. Virol. 2006;80:11539&#x2013;11555. doi: 10.1128/JVI.01016-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01016-06</ArticleId><ArticleId IdType="pmc">PMC1642592</ArticleId><ArticleId IdType="pubmed">16987970</ArticleId></ArticleIdList></Reference><Reference><Citation>Wekerle H. Epstein-Barr virus sparks brain autoimmunity in multiple sclerosis. Nature. 2022;603:230&#x2013;232. doi: 10.1038/d41586-022-00382-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00382-2</ArticleId><ArticleId IdType="pubmed">35169323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanno H., Watabe D., Shimizu N., Sawai T. Adhesion of Epstein&#x2013;Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines. Clin. Exp. Immunol. 2008;151:519&#x2013;527. doi: 10.1111/j.1365-2249.2007.03584.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2007.03584.x</ArticleId><ArticleId IdType="pmc">PMC2276960</ArticleId><ArticleId IdType="pubmed">18190605</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman W.J., Williams M.V., Lemeshow S., Binkley P., Guttridge D., Kiecolt-Glaser J.K., Knight D.A., Ladner K.J., Glaser R. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: Evidence for depression-induced atherosclerotic risk. Brain Behav. Immun. 2008;22:215&#x2013;223. doi: 10.1016/j.bbi.2007.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.07.007</ArticleId><ArticleId IdType="pmc">PMC2245868</ArticleId><ArticleId IdType="pubmed">17845840</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett M.M., Williams M.V., Lemeshow S., Binkley P., Guttridge D., Kiecolt-Glaser J.K., Knight D.A., Ladner K.J., Glaser R. Lymphocytic Arteritis in Epstein&#x2013;Barr Virus Vulvar Ulceration (Lipsch&#xfc;tz Disease): A Report of 7 Cases. Am. J. Dermatopathol. 2015;37:691&#x2013;698. doi: 10.1097/DAD.0000000000000316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DAD.0000000000000316</ArticleId><ArticleId IdType="pubmed">26291418</ArticleId></ArticleIdList></Reference><Reference><Citation>Indari O., Chandramohanadas R., Jha H.C. Epstein&#x2013;Barr virus infection modulates blood&#x2013;brain barrier cells and its co-infection with Plasmodium falciparum induces RBC adhesion. Pathog. Dis. 2020;79:ftaa080. doi: 10.1093/femspd/ftaa080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femspd/ftaa080</ArticleId><ArticleId IdType="pubmed">33355336</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D.-K., Chen X.-R., Wang L.-N., Wang J.-H., Li J.-K., Zhou Z.-Y., Li X., Cai L.-B., Zhong S.-S., Zhang J.-J., et al. Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis. Cancer Gene Ther. 2022;29:1439&#x2013;1451. doi: 10.1038/s41417-022-00453-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41417-022-00453-6</ArticleId><ArticleId IdType="pmc">PMC9576596</ArticleId><ArticleId IdType="pubmed">35388172</ArticleId></ArticleIdList></Reference><Reference><Citation>Granato M., Santarelli R., Farina A., Gonnella R., Lotti L.V., Faggioni A., Cirone M. Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication. J. Virol. 2014;88:12715&#x2013;12726. doi: 10.1128/JVI.02199-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02199-14</ArticleId><ArticleId IdType="pmc">PMC4248894</ArticleId><ArticleId IdType="pubmed">25142602</ArticleId></ArticleIdList></Reference><Reference><Citation>Baglio S.R., van Eijndhoven M.A.J., Koppers-Lalic D., Berenguer J., Lougheed S.M., Gibbs S., L&#xe9;veill&#xe9; N., Rinkel R.N.P.M., Hopmans E.S., Swaminathan S., et al. Sensing of latent EBV infection through exosomal transfer of 5&#x2032;pppRNA. Proc. Natl. Acad. Sci. USA. 2016;113:E587&#x2013;E596. doi: 10.1073/pnas.1518130113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1518130113</ArticleId><ArticleId IdType="pmc">PMC4747727</ArticleId><ArticleId IdType="pubmed">26768848</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara R.P., Chugh P.E., Bailey A., Costantini L.M., Ma Z., Bigi R., Cheves A., Eason A.B., Landis J.T., Host K.M., et al. Extracellular vesicles from Kaposi Sarcoma-associated herpesvirus lymphoma induce long-term endothelial cell reprogramming. PLOS Pathog. 2019;15:e1007536. doi: 10.1371/journal.ppat.1007536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007536</ArticleId><ArticleId IdType="pmc">PMC6361468</ArticleId><ArticleId IdType="pubmed">30716130</ArticleId></ArticleIdList></Reference><Reference><Citation>Takatsuka H., Wakae T., Mori A., Okada M., Fujimori Y., Takemoto Y., Okamoto T., Kanamaru A., Kakishita E. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant. 2003;31:475&#x2013;479. doi: 10.1038/sj.bmt.1703879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bmt.1703879</ArticleId><ArticleId IdType="pubmed">12665843</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda Y., Hara J., Miyoshi H., Osugi Y., Fujisaki H., Takai K., Ohta H., Tanaka-Taya K., Yamanishi K., Okada S. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children. Bone Marrow Transplant. 1999;24:919&#x2013;923. doi: 10.1038/sj.bmt.1702003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bmt.1702003</ArticleId><ArticleId IdType="pubmed">10516706</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioda S., Kasai F., Ozawa M., Hirayama N., Satoh M., Kameoka Y., Watanabe K., Shimizu N., Tang H., Mori Y., et al. The human vascular endothelial cell line HUV-EC-C harbors the integrated HHV-6B genome which remains stable in long term culture. Cytotechnology. 2018;70:141&#x2013;152. doi: 10.1007/s10616-017-0119-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10616-017-0119-y</ArticleId><ArticleId IdType="pmc">PMC5809643</ArticleId><ArticleId IdType="pubmed">28755030</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallbracht K.B., Schwimmbeck P.L., Kuhl U., Rauch U., Seeberg B., Schultheiss H.-P. Differential Aspects of Endothelial Function of the Coronary Microcirculation Considering Myocardial Virus Persistence, Endothelial Activation, and Myocardial Leukocyte Infiltrates. Circulation. 2005;111:1784&#x2013;1791. doi: 10.1161/01.CIR.0000160863.30496.9B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000160863.30496.9B</ArticleId><ArticleId IdType="pubmed">15809378</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximilian Buja L. HHV-6 in Cardiovascular Pathology. In: Krueger G., Ablashi D., editors. Perspectives in Medical Virology. Elsevier; Amsterdam, The Netherlands: 2006. pp. 233&#x2013;241.</Citation></Reference><Reference><Citation>K&#xfc;hl U., Lassner D., Wallaschek N., Gross U.M., Krueger G.R., Seeberg B., Kaufer B.B., Escher F., Poller W., Schultheiss H. Chromosomally integrated human herpesvirus 6 in heart failure: Prevalence and treatment. Eur. J. Heart Fail. 2015;17:9&#x2013;19. doi: 10.1002/ejhf.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.194</ArticleId><ArticleId IdType="pubmed">25388833</ArticleId></ArticleIdList></Reference><Reference><Citation>Comar M., D&#x2019;Agaro P., Campello C., Poli A., Breinholt J.P., A Towbin J., Vatta M. Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J. Clin. Pathol. 2009;62:80&#x2013;83. doi: 10.1136/jcp.2008.059568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2008.059568</ArticleId><ArticleId IdType="pubmed">18818265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada A., Muramatsu K., Sunaga Y., Mizuno T., Takei M., Ogasawara S., Uchida M., Tsukida K., Tashiro M. Brainstem infarction associated with HHV-6 infection in an infant. Brain Dev. 2018;40:242&#x2013;246. doi: 10.1016/j.braindev.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.braindev.2017.09.005</ArticleId><ArticleId IdType="pubmed">28958731</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan Y., Gottlieb D.J., Baewer D., Blyth E. A fatal case of acute HHV-6 myocarditis following allogeneic haemopoietic stem cell transplantation. J. Clin. Virol. 2015;72:82&#x2013;84. doi: 10.1016/j.jcv.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.09.013</ArticleId><ArticleId IdType="pubmed">26465970</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveque N., Boulagnon C., Brasselet C., Lesaffre F., Boutolleau D., Metz D., Fornes P., Andreoletti L. A fatal case of Human Herpesvirus 6 chronic myocarditis in an immunocompetent adult. J. Clin. Virol. 2011;52:142&#x2013;145. doi: 10.1016/j.jcv.2011.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.06.017</ArticleId><ArticleId IdType="pubmed">21802354</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher F., Escher F., Kuehl U., Lassner D., Poller W., Tschoepe C., Schultheiss H.-P. Cardiac involvement of human herpesvirus 6 in patients with inflammatory cardiomyopathy. J. Am. Coll. Cardiol. 2015;65((Suppl. S10)):A945. doi: 10.1016/S0735-1097(15)60945-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(15)60945-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahrholdt H., Wagner A., Deluigi C.C., Kispert E., Hager S., Meinhardt G., Vogelsberg H., Fritz P., Dippon J., Bock C.T., et al. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis. Circulation. 2006;114:1581&#x2013;1590. doi: 10.1161/CIRCULATIONAHA.105.606509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.606509</ArticleId><ArticleId IdType="pubmed">17015795</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyahara H., Miyakawa K., Nishida H., Yano S., Sonoda T., Suenobu S.-I., Izumi T., Daa T., Ihara K. Unique cell tropism of HHV-6B in an infantile autopsy case of primary HHV-6B encephalitis. Neuropathology. 2018;38:400&#x2013;406. doi: 10.1111/neup.12462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12462</ArticleId><ArticleId IdType="pubmed">29582466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda T., Miyake Y., Imoto K., Hattori S., Miyake S., Ishizaki T., Yamada A., Kurata T., Nagai T., Suga S., et al. Distribution of human herpesvirus 6 and varicella-zoster virus in organs of a fatal case with exanthem subitum and varicella. Acta Paediatr. Jpn. 1996;38:590&#x2013;595. doi: 10.1111/j.1442-200X.1996.tb03713.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200X.1996.tb03713.x</ArticleId><ArticleId IdType="pubmed">9002291</ArticleId></ArticleIdList></Reference><Reference><Citation>Harberts E., Yao K., Wohler J.E., Maric D., Ohayon J., Henkin R., Jacobson S. Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. Proc. Natl. Acad. Sci. USA. 2011;108:13734&#x2013;13739. doi: 10.1073/pnas.1105143108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1105143108</ArticleId><ArticleId IdType="pmc">PMC3158203</ArticleId><ArticleId IdType="pubmed">21825120</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshikawa T., Asano Y. Central nervous system complications in human herpesvirus-6 infection. Brain Dev. 2000;22:307&#x2013;314. doi: 10.1016/S0387-7604(00)00113-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0387-7604(00)00113-3</ArticleId><ArticleId IdType="pubmed">10891638</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliassen E., Hemond C.C., Santoro J.D. HHV-6-Associated Neurological Disease in Children: Epidemiologic, Clinical, Diagnostic, and Treatment Considerations. Pediatr. Neurol. 2020;105:10&#x2013;20. doi: 10.1016/j.pediatrneurol.2019.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2019.10.004</ArticleId><ArticleId IdType="pubmed">31932119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolini L., Theodore W.H., Jacobson S., Gaillard W.D. Infection with HHV-6 and its role in epilepsy. Epilepsy Res. 2019;153:34&#x2013;39. doi: 10.1016/j.eplepsyres.2019.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2019.03.016</ArticleId><ArticleId IdType="pubmed">30953871</ArticleId></ArticleIdList></Reference><Reference><Citation>Santpere G., Telford M., Andr&#xe9;s-Benito P., Navarro A., Ferrer I. The Presence of Human Herpesvirus 6 in the Brain in Health and Disease. Biomolecules. 2020;10:1520. doi: 10.3390/biom10111520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10111520</ArticleId><ArticleId IdType="pmc">PMC7694807</ArticleId><ArticleId IdType="pubmed">33172107</ArticleId></ArticleIdList></Reference><Reference><Citation>Romeo M.A., Montani M.S.G., Gaeta A., D&#x2019;Orazi G., Faggioni A., Cirone M. HHV-6A infection dysregulates autophagy/UPR interplay increasing beta amyloid production and tau phosphorylation in astrocytoma cells as well as in primary neurons, possible molecular mechanisms linking viral infection to Alzheimer&#x2019;s disease. Biochim. Biophys. Acta Mol. Basis Dis. 2020;1866:165647. doi: 10.1016/j.bbadis.2019.165647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.165647</ArticleId><ArticleId IdType="pubmed">31866416</ArticleId></ArticleIdList></Reference><Reference><Citation>Romeo M.A., Santarelli R., Montani M.S.G., Gonnella R., Benedetti R., Faggioni A., Cirone M. Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV. Cells. 2020;9:2624. doi: 10.3390/cells9122624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9122624</ArticleId><ArticleId IdType="pmc">PMC7762304</ArticleId><ArticleId IdType="pubmed">33297368</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynaud J.M., J&#xe9;gou J.-F., Welsch J.C., Horvat B. Human herpesvirus 6A infection in CD46 transgenic mice: Viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9. J. Virol. 2014;88:5421&#x2013;5436. doi: 10.1128/JVI.03763-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03763-13</ArticleId><ArticleId IdType="pmc">PMC4019085</ArticleId><ArticleId IdType="pubmed">24574405</ArticleId></ArticleIdList></Reference><Reference><Citation>Flamand L., Gosselin J., D&#x2019;Addario M., Hiscott J., Ablashi D.V., Gallo R.C., Menezes J. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J. Virol. 1991;65:5105&#x2013;5110. doi: 10.1128/jvi.65.9.5105-5110.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.65.9.5105-5110.1991</ArticleId><ArticleId IdType="pmc">PMC248979</ArticleId><ArticleId IdType="pubmed">1651426</ArticleId></ArticleIdList></Reference><Reference><Citation>Flamand L., Menezes J. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J. Virol. 1996;70:1784&#x2013;1791. doi: 10.1128/jvi.70.3.1784-1791.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.70.3.1784-1791.1996</ArticleId><ArticleId IdType="pmc">PMC190004</ArticleId><ArticleId IdType="pubmed">8627701</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C., Rowe P.C., Visser F.C. Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) J. Transl. Med. 2021;19:193. doi: 10.1186/s12967-021-02819-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02819-0</ArticleId><ArticleId IdType="pmc">PMC8097965</ArticleId><ArticleId IdType="pubmed">33947430</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C.M.C., Visser F.C. Comparison of the Degree of Deconditioning in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients with and without Orthostatic Intolerance. Med. Res. Arch. 2022;10:2058. doi: 10.18103/mra.v10i6.2858.</Citation><ArticleIdList><ArticleId IdType="doi">10.18103/mra.v10i6.2858</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., Bahl J.S., Buckley J.D., Thomson R.L., Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. Medicine. 2019;98:e17600. doi: 10.1097/MD.0000000000017600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017600</ArticleId><ArticleId IdType="pmc">PMC6824690</ArticleId><ArticleId IdType="pubmed">31651868</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallet B. Endothelial cell dysfunction and abnormal tissue perfusion. Crit. Care Med. 2002;30((Suppl. S5)):S229&#x2013;S234. doi: 10.1097/00003246-200205001-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200205001-00010</ArticleId><ArticleId IdType="pubmed">12004241</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy B.I., Schiffrin E., Mourad J.-J., Agostini D., Vicaut E., Safar M.E., Struijker-Boudier H.A. Impaired tissue perfusion: A pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008;118:968&#x2013;976. doi: 10.1161/CIRCULATIONAHA.107.763730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.763730</ArticleId><ArticleId IdType="pubmed">18725503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauersachs J., Widder J.D. Endothelial dysfunction in heart failure. Pharmacol. Rep. 2008;60:119&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">18276993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasdai D., Gibbons R.J., HolmesJr D.R., Higano S.T., Lerman A. Coronary Endothelial Dysfunction in Humans Is Associated With Myocardial Perfusion Defects. Circulation. 1997;96:3390&#x2013;3395. doi: 10.1161/01.CIR.96.10.3390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.96.10.3390</ArticleId><ArticleId IdType="pubmed">9396432</ArticleId></ArticleIdList></Reference><Reference><Citation>Machin D.R., Bloom S.I., Campbell R.A., Phuong T.T.T., Gates P.E., Lesniewski L.A., Rondina M.T., Donato A.J. Advanced age results in a diminished endothelial glycocalyx. Am. J. Physiol.-Heart Circ. Physiol. 2018;315:H531&#x2013;H539. doi: 10.1152/ajpheart.00104.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00104.2018</ArticleId><ArticleId IdType="pmc">PMC6172638</ArticleId><ArticleId IdType="pubmed">29750566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozbek O., Ko&#xe7; O., Paksoy Y., Aydin K., Nayman A. Epstein-Barr virus encephalitis: Findings of MRI, MRS, diffusion and perfusion. Turk. J. Pediatr. 2011;53:680&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">22389991</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshinari S., Hamano S.-I., Minamitani M., Tanaka M., Eto Y. Human Herpesvirus 6 Encephalopathy Predominantly Affecting the Frontal Lobes. Pediatr. Neurol. 2007;36:13&#x2013;16. doi: 10.1016/j.pediatrneurol.2006.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2006.09.002</ArticleId><ArticleId IdType="pubmed">17162191</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo Y.-T., Chiu N.-C., Shen E.-Y., Ho C.-S., Wu M.-C. Cerebral perfusion in children with Alice in Wonderland syndrome. Pediatr. Neurol. 1998;19:105&#x2013;108. doi: 10.1016/S0887-8994(98)00037-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-8994(98)00037-X</ArticleId><ArticleId IdType="pubmed">9744628</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghavi S., Abdullah S., Shaheen F., Mueller L., Gagen B., Duchesne J., Steele C., Pociask D., Kolls J., Jackson-Weaver O. Glycocalyx degradation and the endotheliopathy of viral infection. PLoS ONE. 2022;17:e0276232. doi: 10.1371/journal.pone.0276232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276232</ArticleId><ArticleId IdType="pmc">PMC9581367</ArticleId><ArticleId IdType="pubmed">36260622</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Jilma B., Kopp C.W., Ertl S., Gremmel T., Koppensteiner R. Glycocalyx as Possible Limiting Factor in COVID-19. Front. Immunol. 2021;12:607306. doi: 10.3389/fimmu.2021.607306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.607306</ArticleId><ArticleId IdType="pmc">PMC7937603</ArticleId><ArticleId IdType="pubmed">33692785</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasawa M., Hiramoto K., Uchida R., Suzuki K. Anti-Inflammatory Activity of Orally Administered Monostroma nitidum Rhamnan Sulfate against Lipopolysaccharide-Induced Damage to Mouse Organs and Vascular Endothelium. Mar. Drugs. 2022;20:121. doi: 10.3390/md20020121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md20020121</ArticleId><ArticleId IdType="pmc">PMC8875490</ArticleId><ArticleId IdType="pubmed">35200650</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pasquale V., Quiccione M.S., Tafuri S., Avallone L., Pavone L.M. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2. Int. J. Mol. Sci. 2021;22:6574. doi: 10.3390/ijms22126574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126574</ArticleId><ArticleId IdType="pmc">PMC8235362</ArticleId><ArticleId IdType="pubmed">34207476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.H., Dane M.J.C., van den Berg B.M., Boels M.G.S., Van Teeffelen J.W., De Mutsert R., den Heijer M., Rosendaal F.R., Van der Vlag J., van Zonneveld A.J., et al. Deeper Penetration of Erythrocytes into the Endothelial Glycocalyx Is Associated with Impaired Microvascular Perfusion. PLoS ONE. 2014;9:e96477. doi: 10.1371/journal.pone.0096477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0096477</ArticleId><ArticleId IdType="pmc">PMC4015985</ArticleId><ArticleId IdType="pubmed">24816787</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurskens D.M., Bol M., Delhaas T., van de Poll M.C., Reutelingsperger C.P., Nicolaes G.A., Sels J.-W.E. Decreased endothelial glycocalyx thickness is an early predictor of mortality in sepsis. Anaesth. Intensive Care. 2020;48:221&#x2013;228. doi: 10.1177/0310057X20916471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X20916471</ArticleId><ArticleId IdType="pmc">PMC7328096</ArticleId><ArticleId IdType="pubmed">32486831</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrales P., V&#xe1;zquez B.Y.S., Tsai A.G., Intaglietta M. Microvascular and capillary perfusion following glycocalyx degradation. J. Appl. Physiol. 2007;102:2251&#x2013;2259. doi: 10.1152/japplphysiol.01155.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.01155.2006</ArticleId><ArticleId IdType="pubmed">17347383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell D., Westphal M., Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr. Opin. Anesthesiol. 2009;22:155&#x2013;162. doi: 10.1097/ACO.0b013e328328d1b6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e328328d1b6</ArticleId><ArticleId IdType="pubmed">19307890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I., Pavlidis G., Lambadiari V., Rafouli-Stergiou P., Makavos G., Thymis J., Kostelli G., Varoudi M., Katogiannis K., Theodoropoulos K., et al. Endothelial glycocalyx and microvascular perfusion are associated with carotid intima-media thickness and impaired myocardial deformation in psoriatic disease. J. Hum. Hypertens. 2022;36:1113&#x2013;1120. doi: 10.1038/s41371-021-00640-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-021-00640-2</ArticleId><ArticleId IdType="pubmed">34819613</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E., Soffritti I., D&#x2019;accolti M., Bortolotti D., Rizzo R., Sighinolfi G., Giuggioli D., Ferri C. HHV-6A Infection and Systemic Sclerosis: Clues of a Possible Association. Microorganisms. 2020;8:39. doi: 10.3390/microorganisms8010039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8010039</ArticleId><ArticleId IdType="pmc">PMC7022325</ArticleId><ArticleId IdType="pubmed">31878218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E., Achua J., Saltzman R., Khodamoradi K., Arora H., Ibrahim E., Kryvenko O.N., Almeida V.W., Firdaus F., Hare J.M., et al. COVID-19 Endothelial Dysfunction Can Cause Erectile Dysfunction: Histopathological, Immunohistochemical, and Ultrastructural Study of the Human Penis. World J. Mens. Health. 2021;39:466&#x2013;469. doi: 10.5534/wjmh.210055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210055</ArticleId><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimenti C., Verardo R., Grande C., Francone M., Frustaci A. Infarct-like myocarditis with coronary vasculitis and aneurysm formation caused by Epstein&#x2013;Barr virus infection. ESC Heart Fail. 2020;7:938&#x2013;941. doi: 10.1002/ehf2.12611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12611</ArticleId><ArticleId IdType="pmc">PMC7261578</ArticleId><ArticleId IdType="pubmed">32187886</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal O., Sahel N., Saouab R., El Qatni M., Zaizaa M., El Kassimi I., Rkiouak A., Hammi S., Sekkach Y. Fatal Systemic Vasculitis Associated with Chronic Active Epstein-Barr Virus Infection. Mo. Med. 2021;118:226&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8210988</ArticleId><ArticleId IdType="pubmed">34149082</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto A., Angelici S., Soligo M., Di Giuda D., Manni L., Curatola A., Ferretti S., Chiaretti A. Pediatric cerebral stroke induced by Epstein-Barr virus infection: Role of Interelukin overexpression. Acta Biomed. 2021;92((Suppl. S1)):e2021135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142774</ArticleId><ArticleId IdType="pubmed">33944821</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader M.S., Haroon B., Trahey J., Al-Musawi A., Hawboldt J.B. Disseminated Intravascular Coagulation and Venous Thromboembolism Due to Acute Epstein-Barr Virus Infection. Infect. Dis. Clin. Pract. 2011;19:284&#x2013;285. doi: 10.1097/IPC.0b013e3181fc6e7c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IPC.0b013e3181fc6e7c</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor D.S., Elmariah S., Aledort L., Pinney S. Disseminated Intravascular Coagulation Complicating Epstein-Barr Virus Infection in a Cardiac Transplant Recipient: A Case Report. Transplant. Proc. 2010;42:1973&#x2013;1975. doi: 10.1016/j.transproceed.2009.11.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2009.11.044</ArticleId><ArticleId IdType="pubmed">20620559</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer M.P., Young A.M.H., O&#x2019;leary R., Damian M.S., Lavinio A. Probable Catastrophic Antiphospholipid Syndrome with Intracerebral Hemorrhage Secondary to Epstein&#x2013;Barr Viral Infection. Neurocritical Care. 2018;28:127&#x2013;132. doi: 10.1007/s12028-017-0392-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-017-0392-9</ArticleId><ArticleId IdType="pubmed">28357636</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka S., Nohgawa M. EB virus reactivation triggers thrombotic thrombocytopenic purpura in a healthy adult. Leuk. Res. Rep. 2017;8:1&#x2013;3. doi: 10.1016/j.lrr.2017.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lrr.2017.06.001</ArticleId><ArticleId IdType="pmc">PMC5487301</ArticleId><ArticleId IdType="pubmed">28702343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashav N., Saar N., Chundadze T., Steinvil A., Justo D. Epstein-Barr virus-associated venous thromboembolism: A case report and review of the literature. Thromb. Res. 2008;122:570&#x2013;571. doi: 10.1016/j.thromres.2008.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2008.03.005</ArticleId><ArticleId IdType="pubmed">18407322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hal S.V., Senanayake S., Hardiman R. Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection. J. Clin. Virol. 2005;32:245&#x2013;247. doi: 10.1016/j.jcv.2004.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2004.07.013</ArticleId><ArticleId IdType="pubmed">15722031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Zhao X., Zhu X., Shi J., Liu L., Wang X., Xie M., Ma C., Hu Y., Sun J. Functional analysis and expression profile of human platelets infected by EBV in vitro. Infect. Genet. Evol. 2022;102:105312. doi: 10.1016/j.meegid.2022.105312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105312</ArticleId><ArticleId IdType="pubmed">35667565</ArticleId></ArticleIdList></Reference><Reference><Citation>Winiarski J. Antibodies to platelet membrane glycoprotein antigens in three cases of infectious mononucleosis-induced thrombocytopenic purpura. Eur. J. Haematol. 1989;43:29&#x2013;34. doi: 10.1111/j.1600-0609.1989.tb01247.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0609.1989.tb01247.x</ArticleId><ArticleId IdType="pubmed">2767240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Kamijo T., Nakazawa Y., Kurokawa Y., Sakashita K., Komiyama A., Koike K., Ueno I., Fujisawa K. Specific autoantibodies to platelet glycoproteins in Epstein-Barr virus-associated immune thrombocytopenia. Int. J. Hematol. 2003;78:168&#x2013;170. doi: 10.1007/BF02983388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02983388</ArticleId><ArticleId IdType="pubmed">12953814</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimori M., Nishio M., Ohashi A., Tateishi M., Mimura A., Wada N., Saito M., Shimizu N., Imadome K.-I., Arai A. Interferon-&#x3b3; Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH. Cancers. 2021;13:5097. doi: 10.3390/cancers13205097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13205097</ArticleId><ArticleId IdType="pmc">PMC8533691</ArticleId><ArticleId IdType="pubmed">34680246</ArticleId></ArticleIdList></Reference><Reference><Citation>Belford A., Myles O., Magill A., Wang J., Myhand R.C., Waselenko J.K. Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation. Am. J. Hematol. 2004;76:156&#x2013;162. doi: 10.1002/ajh.20068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.20068</ArticleId><ArticleId IdType="pubmed">15164383</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Cao Y., Ma L., Pei H., Rausch W.D., Li H. Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia. Front. Aging Neurosci. 2018;10:376. doi: 10.3389/fnagi.2018.00376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00376</ArticleId><ArticleId IdType="pmc">PMC6250852</ArticleId><ArticleId IdType="pubmed">30505270</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem M., Herrmann N., Dinoff A., Mazereeuw G., Oh P.I., Goldstein B.I., Kiss A., Shammi P., Lanct&#xf4;t K.L. Association Between Endothelial Function and Cognitive Performance in Patients with Coronary Artery Disease During Cardiac Rehabilitation. Psychosom. Med. 2019;81:184&#x2013;191. doi: 10.1097/PSY.0000000000000651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000651</ArticleId><ArticleId IdType="pmc">PMC6365250</ArticleId><ArticleId IdType="pubmed">30383709</ArticleId></ArticleIdList></Reference><Reference><Citation>Buie J.J., Watson L.S., Smith C.J., Sims-Robinson C. Obesity-related cognitive impairment: The role of endothelial dysfunction. Neurobiol. Dis. 2019;132:104580. doi: 10.1016/j.nbd.2019.104580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104580</ArticleId><ArticleId IdType="pmc">PMC6834913</ArticleId><ArticleId IdType="pubmed">31454547</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedel B., Browne K., Silbert B. Cerebral protection: Inflammation, endothelial dysfunction, and postoperative cognitive dysfunction. Curr. Opin. Anesthesiol. 2014;27:89&#x2013;97. doi: 10.1097/ACO.0000000000000032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000032</ArticleId><ArticleId IdType="pubmed">24300462</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld O.N., Berg E.v.D., Johansen O.E., Schnaidt S., Hermansson K., Zinman B., A Espeland M., Biessels G.J. Oxidative stress and endothelial dysfunction are associated with reduced cognition in type 2 diabetes. Diab. Vasc. Dis. Res. 2019;16:577&#x2013;581. doi: 10.1177/1479164119848093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1479164119848093</ArticleId><ArticleId IdType="pubmed">31068001</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozal D., Kheirandish-Gozal L., Bhattacharjee R., Spruyt K. Neurocognitive and Endothelial Dysfunction in Children with Obstructive Sleep Apnea. Pediatrics. 2010;126:e1161&#x2013;e1167. doi: 10.1542/peds.2010-0688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-0688</ArticleId><ArticleId IdType="pubmed">20956420</ArticleId></ArticleIdList></Reference><Reference><Citation>Heringa S., Berg E.v.D., Reijmer Y., Nijpels G., Stehouwer C., Schalkwijk C., Teerlink T., Scheffer P., Hurk K.v.D., Kappelle L., et al. Markers of low-grade inflammation and endothelial dysfunction are related to reduced information processing speed and executive functioning in an older population&#x2014;The Hoorn Study. Psychoneuroendocrinology. 2014;40:108&#x2013;118. doi: 10.1016/j.psyneuen.2013.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2013.11.011</ArticleId><ArticleId IdType="pubmed">24485482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun S.-M., Park J.-Y., Seo S.W., Song J. Association of plasma endothelial lipase levels on cognitive impairment. BMC Psychiatry. 2019;19:187. doi: 10.1186/s12888-019-2174-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-019-2174-8</ArticleId><ArticleId IdType="pmc">PMC6585097</ArticleId><ArticleId IdType="pubmed">31216999</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Filho R.K., Zotin M.C., Rodrigues G., Pontes-Neto O. Biomarkers Related to Endothelial Dysfunction and Vascular Cognitive Impairment: A Systematic Review. Dement. Geriatr. Cogn. Disord. 2020;49:365&#x2013;374. doi: 10.1159/000510053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000510053</ArticleId><ArticleId IdType="pubmed">33045717</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;ie M.G., R&#xf8;d&#xf8; A.S.B., B&#xf8;lgen M.S., Pedersen M., Asprusten T.T., Wyller V.B.B. Subjective and objective cognitive function in adolescent with chronic fatigue following Epstein-Barr virus infection. J. Psychosom. Res. 2022;163:111063. doi: 10.1016/j.jpsychores.2022.111063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2022.111063</ArticleId><ArticleId IdType="pubmed">36327530</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim S.-M., Cheon H.-S., Jo C., Koh Y.H., Song J., Jeon J.-P. Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly. J. Alzheimers Dis. 2017;55:293&#x2013;301. doi: 10.3233/JAD-160563.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160563</ArticleId><ArticleId IdType="pubmed">27589534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarchini G. Human Herpesviruses HHV-6A, HHV-6B &amp; HHV-7: Diagnosis and Clinical Management. 3rd ed. Clin. Infect. Dis. 2014;60:496&#x2013;497.</Citation></Reference><Reference><Citation>Huang C., Liu W., Ren X., Lv Y., Wang L., Huang J., Zhu F., Wu D., Zhou L., Huang X., et al. Association between human herpesvirus 6 (HHV-6) and cognitive function in the elderly population in Shenzhen, China. Aging Clin. Exp. Res. 2022;34:2407&#x2013;2415. doi: 10.1007/s40520-022-02170-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-022-02170-4</ArticleId><ArticleId IdType="pubmed">35767152</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Shigihara Y., Funakura M., Kanai E., Watanabe Y. Fatigue-associated alterations of cognitive function and electroencephalographic power densities. PLoS ONE. 2012;7:e34774. doi: 10.1371/journal.pone.0034774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034774</ArticleId><ArticleId IdType="pmc">PMC3326030</ArticleId><ArticleId IdType="pubmed">22514666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerr D.M., Fann J.R., Breiger D., Boeckh M., Adler A.L., Xie H., Delaney C., Huang M.-L., Corey L., Leisenring W.M. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood. 2011;117:5243&#x2013;5249. doi: 10.1182/blood-2010-10-316083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-10-316083</ArticleId><ArticleId IdType="pmc">PMC3109545</ArticleId><ArticleId IdType="pubmed">21389320</ArticleId></ArticleIdList></Reference><Reference><Citation>Navone S.E., Marfia G., Invernici G., Cristini S., Nava S., Balbi S., Sangiorgi S., Ciusani E., Bosutti A., Alessandri G., et al. Isolation and expansion of human and mouse brain microvascular endothelial cells. Nat. Protoc. 2013;8:1680&#x2013;1693. doi: 10.1038/nprot.2013.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.107</ArticleId><ArticleId IdType="pubmed">23928501</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas-Hernandez H., Cuevas E., Lantz S.M., Paule M.G., Ali S.F. Isolation and Culture of Brain Microvascular Endothelial Cells for In Vitro Blood-Brain Barrier Studies. Methods Mol. Biol. 2018;1727:315&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">29222791</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno-Bet&#xed; C., Novella S., L&#xe1;zaro-Franco M., P&#xe9;rez-Cremades D., Heras M., Sanch&#xed;s J., Hermenegildo C. An affordable method to obtain cultured endothelial cells from peripheral blood. J. Cell. Mol. Med. 2013;17:1475&#x2013;1483. doi: 10.1111/jcmm.12133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12133</ArticleId><ArticleId IdType="pmc">PMC4117560</ArticleId><ArticleId IdType="pubmed">24118735</ArticleId></ArticleIdList></Reference><Reference><Citation>Okumura N., Kusakabe A., Hirano H., Inoue R., Okazaki Y., Nakano S., Kinoshita S., Koizumi N. Density-gradient centrifugation enables the purification of cultured corneal endothelial cells for cell therapy by eliminating senescent cells. Sci. Rep. 2015;5:15005. doi: 10.1038/srep15005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15005</ArticleId><ArticleId IdType="pmc">PMC4595725</ArticleId><ArticleId IdType="pubmed">26443440</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Li X., Tulpule A., Zhou Y., Scehnet J.S., Zhang S., Lee J.-S., Chaudhary P.M., Jung J., Gill P.S. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010;115:887&#x2013;895. doi: 10.1182/blood-2009-08-236745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-08-236745</ArticleId><ArticleId IdType="pmc">PMC2815507</ArticleId><ArticleId IdType="pubmed">19965636</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian L.-W., Greene W., Ye F., Gao S.-J. Kaposi&#x2019;s Sarcoma-Associated Herpesvirus Disrupts Adherens Junctions and Increases Endothelial Permeability by Inducing Degradation of VE-Cadherin. J. Virol. 2008;82:11902&#x2013;11912. doi: 10.1128/JVI.01042-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01042-08</ArticleId><ArticleId IdType="pmc">PMC2583667</ArticleId><ArticleId IdType="pubmed">18815301</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercellotti G.M. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul. Fibrinolysis. 1998;9((Suppl. S2)):S3&#x2013;S6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9662464</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y.H., Utama B., Wang J., Raveendran M., Senthil D., Waldman W., Belcher J., Vercellotti G., Martin D., Mitchelle B., et al. Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ. Res. 2004;94:1310&#x2013;1317. doi: 10.1161/01.RES.0000129180.13992.43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000129180.13992.43</ArticleId><ArticleId IdType="pmc">PMC1350949</ArticleId><ArticleId IdType="pubmed">15105295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>